Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans

References

• BarrattGBretagneSOptimizing efficacy of amphotericin B through nanomodificationInt J Nanomedicine2007230131318019830
   PubMed Web of Science ®Google Scholar
• TorradoJJEspadaRBallesterosMPTorrado-SantiagoSAmphotericin B formulations and drug targetingJ Pharm Sci2008972405242517893903
   PubMed Web of Science ®Google Scholar
• KleinbergMWhat is the current and future status of conventional amphotericin B?Int J Antimicrob Agents200627S1121616707251
   PubMedGoogle Scholar
• HaYEPeckKRJooEJImpact of first-line antifungal agents on the outcomes and costs of candidemiaAntimicrob Agents Chemother2012563950395622526315
   PubMed Web of Science ®Google Scholar
• Laniado-LaborinRCabrales-VargasMNAmphotericin B: side effects and toxicityRev Iberoam Micol20092622322719836985
   PubMed Web of Science ®Google Scholar
• GuptaSPalAVyasSPDrug delivery strategies for therapy of visceral leishmaniasisExpert Opin Drug Deliv2010737140220201740
   PubMed Web of Science ®Google Scholar
• DerayGAmphotericin B nephrotoxicityJ Antimicrob Chemother200249S1374111801579
   PubMedGoogle Scholar
• SabraRBranchRAAmphotericin B nephrotoxicityDrug Saf19905941082182052
   PubMed Web of Science ®Google Scholar
• DupontBOverview of the lipid formulations of amphotericin BJ Antimicrob Chemother200249S1313611801578
   PubMedGoogle Scholar
• HerbrechtRNatarajan-AmeSNivoixYLetscher-BruVThe lipid formulations of amphotericin BExpert Opin Pharmacother200341277128712877636
   PubMed Web of Science ®Google Scholar
• AntoniadouADupontBLipid formulations of amphotericin B: where are we today?J Med Mycol200515230238
   Web of Science ®Google Scholar
• Adler-MoorePJProffittTRDevelopment, characterization, efficacy and mode of action of Ambisome, a unilamellar liposomal formulation of Amphotericin BJ Liposome Res19933429450
   Google Scholar
• Adler-MooreJProffittRTAmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experienceJ Antimicrob Chemother200249213011801577
   PubMed Web of Science ®Google Scholar
• BruynesteynKGantVMcKenzieCA cost-effectiveness analysis of caspofungin vs liposomal amphotericin B for treatment of suspected fungal infections in the UKEur J Haematol20077853253917419744
   PubMed Web of Science ®Google Scholar
• OlliaroPDarleySLaxminarayanRSundarSCost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, IndiaTrop Med Int Health20091491892519563434
   PubMed Web of Science ®Google Scholar
• Adler-MooreJPProffittRTAmphotericin B lipid preparations: what are the differences?Clin Microbiol Infect200814S4253618430127
   PubMedGoogle Scholar
• OlsonJAAdler-MooreJPJensenGMComparison of the physicochemical, antifungal, and toxic properties of two liposomal amphotericin B productsAntimicrob Agents Chemother20085225926817967910
   PubMed Web of Science ®Google Scholar
• CifaniCCostantinoSMassiMBerrinoLCommercially available lipid formulations of amphotericin B: are they bioequivalent and therapeutically equivalent?Acta Biomed20128315416323393924
   PubMedGoogle Scholar
• PatelGPCrankCWLeikinJBAn evaluation of hepatotoxicity and nephrotoxicity of liposomal amphotericin B (L-AMB)J Med Toxicol20117121521057910
   PubMedGoogle Scholar
• KumariAYadavSKYadavSCBiodegradable polymeric nanoparticles based drug delivery systemsColloids Surf B Biointerfaces20107511819782542
   PubMed Web of Science ®Google Scholar
• Saffie-SiebertROgdenJParry-BillingsMNanotechnology approaches to solving the problems of poorly water-soluble drugsDrug Discovery World200537176
   Google Scholar
• YangDYuLVanSClinically relevant anticancer polymer paclitaxel therapeuticsCancers (Basel)20113174224212604
   PubMedGoogle Scholar
• KopecekJKopeckováPMinkoTLuZRPetersonCMWater soluble polymers in tumor targeted deliveryJ Control Release20017414715811489491
   PubMed Web of Science ®Google Scholar
• FarazuddinMSharmaBKhanAAJoshiBOwaisMAnticancer efficacy of perillyl alcohol-bearing PLGA microparticlesInt J Nanomedicine20127354722275821
   PubMed Web of Science ®Google Scholar
• FarazuddinMChauhanAKhanRMOwaisMAmoxicillin-bearing microparticles: potential in the treatment of Listeria monocytogenes infection in Swiss albino miceBiosci Rep20113126527220687896
   PubMed Web of Science ®Google Scholar
• WangCFengMDengJPoly(alpha-glutamic acid) combined with polycation as serum-resistant carriers for gene deliveryInt J Pharm201039823724520678564
   PubMedGoogle Scholar
• LiCPoly(L-glutamic acid)-anticancer drug conjugatesAdv Drug Deliv Rev20025469571312204599
   PubMed Web of Science ®Google Scholar
• LiCWallaceSPolymer-drug conjugates: recent development in clinical oncologyAdv Drug Deliv Rev20086088689818374448
   PubMed Web of Science ®Google Scholar
• Paz-AresLRossHO’BrienMPhase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancerBr J Cancer2008981608161318475293
   PubMed Web of Science ®Google Scholar
• SabbatiniPAghajanianCDizonDPhase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinomaJ Clin Oncol2004224523453115542803
   PubMed Web of Science ®Google Scholar
• ChoCSKobayashiATakeiRReceptor-mediated cell modulator delivery to hepatocyte using nanoparticles coated with carbohydrate-carrying polymersBiomaterials200122455111085382
   PubMed Web of Science ®Google Scholar
• Nilsson-EhleIYoshikawaTTEdwardsJESchotzMCGuzeLBQuantitation of amphotericin B with use of high-pressure liquid chromatographyJ Infect Dis1977135414422850079
   PubMed Web of Science ®Google Scholar
• BarwiczJChristianSGrudaIEffects of the aggregation state of amphotericin B in its toxicity to miceAntimicrob Agents Chemother199236231023151444311
   PubMed Web of Science ®Google Scholar
• NaharMDubeyVMishraDMishraPDubeAJainNKIn vitro evaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasisJ Drug Target2010189310519640212
   PubMed Web of Science ®Google Scholar
• OlsonJAAdler-MooreJPSchwartzJJensenGMProffittRTComparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis modelAntimicrob Agents Chemother2006502122213116723574
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards InstituteM27-A2. Vol 22 No 15. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard method2nd ed1-56238-469-4Wayne, PA, USAClinical and Laboratory Standards Institute2002
   Google Scholar
• van EttenEWvan VianenWHakJBakker-WoudenbergIAActivity of liposomal amphotericin B with prolonged circulation in blood versus those of AmBisome and Fungizone against intracellular Candida albicans in murine peritoneal macrophagesAntimicrob Agents Chemother199842243724399736579
   PubMed Web of Science ®Google Scholar
• BachmannSPVan de WalleKRamageGIn vitro activity of caspofungin against Candida albicans biofilmsAntimicrob Agents Chemother2002463591359612384370
   PubMed Web of Science ®Google Scholar
• KuhnDMGeorgeTChandraJMukherjeePKGhannoumMAAntifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandinsAntimicrob Agents Chemother2002461773178012019089
   PubMed Web of Science ®Google Scholar
• VandermeulenGRouxhetLArienABrewsterMEPreatVEncapsulation of amphotericin B in poly(ethylene glycol)-block-poly(ε-caprolactone-co-trimethylene carbonate) polymeric micellesInt J Pharm200630923424016406402
   PubMed Web of Science ®Google Scholar
• ChoiKCBangJYKimPIKimCSongCEAmphotericin B-incorporated polymeric micelles composed of poly-(d,l-lactide-co-glycolide)/dextran graft copolymerInt J Pharm200835522423018242900
   PubMed Web of Science ®Google Scholar
• AdamsMLAndesRDKwonSGAmphotericin B encapsulated in micelles based on poly(ethylene oxide)-block–poly(L-amino acid) derivatives exerts reduced in vitro haemolysis but maintains potent in vivo antifungal activityBiomacromolecules2003475075712741794
   PubMed Web of Science ®Google Scholar
• FalamarzianALavasanifarAOptimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of amphotericin BColloids Surf Biointerfaces201081313320
   PubMed Web of Science ®Google Scholar
• YooBKJalil MiahMALeeESHanKReduced renal toxicity of nanoparticular amphotericin B micelles prepared with partially benzylated poly-L-aspartic acidBiol Pharm Bull2006291700170516880628
   PubMed Web of Science ®Google Scholar
• NishiKKAntonyMMohananPVAnilkumarTVLoiseauPMJayakrishnanAAmphotericin B-gum arabic conjugates: synthesis, toxicity, bioavailability, and activities against Leishmania and fungiPharm Res20072497198017372682
   PubMed Web of Science ®Google Scholar
• ConoverDCZahaoHLongleyBCShumLKGreenwaldBRUtility of poly(ethylene glycol) conjugation to create prodrugs of amphotericin BBioconjug Chem20031466166612757392
   PubMed Web of Science ®Google Scholar
• NicolettiSSeifertKGilbertIHN-(2-hydroxypropyl)-methacrylamide-amphotericin B (HPMA-AmB) copolymer conjugates as antileishmanial agentsInt J Antimicrob Agents20093344144819097763
   PubMed Web of Science ®Google Scholar
• Ehrenfreund-KleinmanTAzzamTFalkRPolacheckIGolenserJDombJASynthesis and characterization of novel water soluble amphotericin B-arabinogalactan conjugatesBiomaterials2002231327133511804288
   PubMed Web of Science ®Google Scholar
• JansookPLoftssonTCDs as solubilizers: effects of excipients and competing drugsInt J Pharm2009379324019524652
   PubMedGoogle Scholar
• CorwareKFHarrisDFTeoIFAccelerated healing of cutaneous leishmaniasis in non-healing BALB/c mice using water soluble amphotericin B-polymethacrylic acidBiomaterials2011328029803921807409
   PubMed Web of Science ®Google Scholar
• KajtarMVikmonMMorlinESzejtliJAggregation of amphotericin B in the presence of gamma-cyclodextrinBiopolymers198928158515962775849
   PubMed Web of Science ®Google Scholar
• OhtaniYIrieTUekamaKFukunagaKPithaJDifferential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytesEur J Biochem198918617222598927
   PubMedGoogle Scholar
• DonaubauerHHFuchsHLangerKHBarASubchronic intravenous toxicity studies with gamma-cyclodextrin in ratsRegul Toxicol Pharmacol1998271891989671574
   PubMed Web of Science ®Google Scholar
• CharvalosETzatzarakisMNVan BambekeFWater soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effectsJ Antimicrob Chemother20065723624416361329
   PubMed Web of Science ®Google Scholar
• SavicRAzzamTEisenbergAMaysingerDAssessment of the integrity of poly(caprolactone)-b-poly(ethylene oxide) micelles under biological conditions: a fluorogenic-based approachLangmuir2006223570357816584228
   PubMed Web of Science ®Google Scholar
• ChenHKimSHeWFast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo Forster resonance energy transfer imagingLangmuir2008245213521718257595
   PubMed Web of Science ®Google Scholar
• AkagiTKanekoTKidaTAkashiMMultifunctional conjugation of proteins on/into bio-nanoparticles prepared by amphiphilic poly(gamma-glutamic acid)J Biomater Sci Polym Ed20061787589217024878
   PubMed Web of Science ®Google Scholar
• LemkeAKiderlenAKayserOAmphotericinBAppl Microbiol Biotechnol20056815116215821914
   PubMed Web of Science ®Google Scholar
• PimpangPChoopunSMonodispersity and stability of gold nanoparticles stabilized by using polyvinyl alcoholChiang Mai J Sci2011383138
   Web of Science ®Google Scholar
• RosenblattKMBunjesHPoly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the alpha-modificationMol Pharm2009610512019049318
   PubMed Web of Science ®Google Scholar
• ProkopAKozlovECarlessoJDavidsonMHydrogel based colloidal polymeric system for protein and drug delivery: physical and chemical characterization permeability control and applicationsAdvances in Polymer Sciences2002160119173
   Web of Science ®Google Scholar
• Beck-BroichsitterMRuppertCSchmehlTBiophysical investigation of pulmonary surfactant surface properties upon contact with polymeric nanoparticles in vitroNanomedicine2011734135021059405
   PubMed Web of Science ®Google Scholar
• PatilaSSandbergAHeckertESelfWSeaSProtein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potentialBiomaterials2007284600460717675227
   PubMed Web of Science ®Google Scholar
• PuttipipatkhachornSNunthanidJYamamotocKPeckGEDrug physical state and drug–polymer interaction on drug release from chitosan matrix filmsJ Control Release20017514315311451504
   PubMed Web of Science ®Google Scholar
• SutherlandMDThorkildsonPParksSDKozelTRIn vivo fate and distribution of poly-gamma-D-glutamic acid, the capsular antigen from Bacillus anthracisInfect Immun20087689990618195035
   PubMed Web of Science ®Google Scholar
• PelkmansLSecrets of caveolae- and lipid raft-mediated endocytosis revealed by mammalian virusesBiochim Biophys Acta2005174629530416126288
   PubMed Web of Science ®Google Scholar
• EspadaRValdespinaSDeaMAIn vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulationJ Antimicrob Chemother2008611125113118285313
   PubMed Web of Science ®Google Scholar
• LegrandPRomeroEACohenBEBolardJEffects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytesAntimicrob Agents Chemother199236251825221489196
   PubMed Web of Science ®Google Scholar
• Sanchez-BruneteJADeaMARamaAAmphotericin B molecular organization as an essential factor to improve activity/toxicity ratio in the treatment of visceral leishmaniasisJ Drug Target20041245346015621670
   PubMed Web of Science ®Google Scholar
• MullenABCarterKCBaillieAJComparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasisAntimicrob Agents Chemother199741208920929333030
   PubMed Web of Science ®Google Scholar
• Lamy-FreundMTFerreiraVFFaljoni-AlarioASchreierSEffect of aggregation on the kinetics of autoxidation of the polyene antibiotic amphotericin BJ Pharm Sci1993821621668383201
   PubMed Web of Science ®Google Scholar
• MazerskiJBorowskiEMolecular dynamics of amphotericin B. II Dimer in waterBiophys Chem1996572052178573677
   PubMed Web of Science ®Google Scholar
• GaboriauFCheronMLeroyLBolardJPhysico-chemical properties of the heat-induced ‘superaggregates’ of amphotericin BBiophys Chem19976611217029866
   PubMed Web of Science ®Google Scholar
• EgitoLCde MedeirosSRMedeirosMGPriceJCEgitoESEvaluation of the relationship of the molecular aggregation state of amphotericin B in medium to its genotoxic potentialJ Pharm Sci2004931557156515124213
   PubMed Web of Science ®Google Scholar
• BolardJLegrandPHeitzFCybulskaBOne-sided action of amphotericin-B on cholesterol-containing membranes is determined by its self-association in the mediumBiochemistry199130570757152043613
   PubMed Web of Science ®Google Scholar
• HartselSBolardJAmphotericin B: new life for an old drugTrends Pharmacol Sci1996174454499014498
   PubMed Web of Science ®Google Scholar
• BrajtburgJBolardJCarrier effects on biological activity of amphotericin BClin Microbiol Rev199695125318894350
   PubMed Web of Science ®Google Scholar
• EspadaRValdespinaSAlfonsoCRivasGBallesterosMPTorradoJJEffect of aggregation state on the toxicity of different amphotericin B preparationsInt J Pharm2008361646918599228
   PubMed Web of Science ®Google Scholar
• ImanMHuangZSzokaFCJaafariMRCharacterization of the colloidal properties, in vitro antifungal activity, antileishmanial activity and toxicity in mice of a di-stigma-steryl hemi-succinoyl-glycero-phosphocholine liposome-intercalated amphotericin BInt J Pharm201140816317221277963
   PubMed Web of Science ®Google Scholar
• JeeJMcCoyAMecozziSEncapsulation and release of amphotericin B from an ABC tri-block fluorous copolymerPharm Res201229698221739321
   PubMed Web of Science ®Google Scholar
• DieziTBaeYKwonGSEnhanced stability of PEG-block poly (N-hexyl stearate l-aspartamide) micelles in the presence of serum proteinsMol Pharm201071355136020575526
   PubMed Web of Science ®Google Scholar
• YangZLLiXRYangKWLiuYAmphotericin B loaded poly(ethylene glycol)-poly(lactide) micelles: preparation, freeze-drying, and in vitro releaseJ Biomed Mater Res A20088553954617729259
   PubMed Web of Science ®Google Scholar
• JainJPKumarNDevelopment of amphotericin B loaded polymersomes based on (PEG)(3)-PLA co-polymers: factors affecting size and in vitro evaluationEur J Pharm Sci20104045646520580669
   PubMed Web of Science ®Google Scholar
• WangCHWangWTHsiueGHDevelopment of polyion complex micelles for encapsulating and delivering amphotericin BBiomaterials2009303352335819299011
   PubMed Web of Science ®Google Scholar
• Skrocka-KnopikABielawskiJThe mechanism of the haemolytic activity of polyene antibioticsCell Mol Biol Lett20027314811944048
   PubMed Web of Science ®Google Scholar
• JensenGMSkenesCRBunchTHDetermination of the relative toxicity of amphotericin B formulations: a red blood cell potassium release assayDrug Deliv199968188
   Web of Science ®Google Scholar
• SperryPJCuaDJWetzelSAAdler-MooreJPAntimicrobial activity of AmBisome and non-liposomal amphotericin B following uptake of Candida glabrata by murine epidermal Langerhans cellsMed Mycol1998361351419776826
   PubMed Web of Science ®Google Scholar
• LeeJWAmanteaMAFrancisPAPharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbitsAntimicrob Agents Chemother1994387137188031034
   PubMed Web of Science ®Google Scholar
• Van EttenEWvan den Heuvel-de GrootCBakker-WoudenbergIAEfficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic miceJ Antimicrob Chemother1993327237398125837
   PubMed Web of Science ®Google Scholar
• LegrandPVertut-DoABolardJComparative internalization and recycling of different amphotericin B formulations by a macrophage-like cell lineJ Antimicrob Chemother1996375195339182109
   PubMed Web of Science ®Google Scholar
• Al-DhaheriRSDouglasLJApoptosis in Candida biofilms exposed to amphotericin BJ Med Microbiol20105914915719892857
   PubMed Web of Science ®Google Scholar
• ChandraJKuhnDMMukherjeePKHoyerLLMcCormickTGhannoumMABiofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistanceJ Bacteriol20011835385539411514524
   PubMed Web of Science ®Google Scholar
• RamageGVandewalleKBachmannSPIn vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studiesAntimicrob Agents Chemother2002463634363612384379
   PubMed Web of Science ®Google Scholar
• BaillieGSDouglasLJEffect of growth rate on resistance of Candida albicans biofilms to antifungal agentsAntimicrob Agents Chemother199842190019059687381
   PubMed Web of Science ®Google Scholar
• StoodleyPSauerKDaviesDGCostertonJWBiofilms as complex differentiated communitiesAnnu Rev Microbiol20025618720912142477
   PubMed Web of Science ®Google Scholar
• HoyerLLPayneTLBellMRelationship between Candida albicans virulence during experimental hematogenously disseminated infection and endothelial cell damage in vitroInfect Immun20047259860114688143
   PubMed Web of Science ®Google Scholar
• LoHJKohlerJRDi DomenicoBLoebenbergDCaccia-PuotiAFinkGRNonfilamentous C. albicans mutants are avirulentCell1997909399499298905
   PubMed Web of Science ®Google Scholar